Analyte meter protectors and methods

• US 7,867,446 B2
• Filed: 09/30/2009
• Issued: 01/11/2011
• Est. Priority Date: 12/26/2006
• Status: Active Grant

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Strasma, Paul, Gary, Kenneth, Arbogast, Frederic, Azzano, Lawrence
• Primary Examiner(s): Alexander; Lyle A
• Assistant Examiner(s): White; Dennis M
• Application Number:
  US12/570,937
• Publication Number:
  US 20100022954A1
• Time in Patent Office: 468 Days
• Field of Search: 422/55, 422/58, 422/61, 422/68.1, 422/82.05, 422/103, 422/104
• US Class Current: 422/68.1
• CPC Class Codes: G01N 33/4875 Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method test-elements per se B01L, automatic analysers G01N35/00, in-vivo analysis on the human body for medical diagnosis A61B
• CPC Class Codes: Y10S 435/817 Enzyme or microbe electrode
• CPC Class Codes: Y10T 436/144444 Glucose

Abstract

Analyte meter protectors, meters that include the same, and methods.

Claims

1. A drug delivery system, comprising:

a drug delivery device;

an in vitro analyte test strip port to receive an in vitro analyte test strip; and

a test strip port protector mateable about the in vitro analyte test strip port, wherein the port protector includes a slot dimensioned to wipe across a surface of the in vitro analyte test strip when the test strip is received therein, and wherein the port protector includes an engagement feature to align and attach the port protector to the port.

2. The drug delivery system of claim 1, wherein the drug delivery device further comprises:

an insulin pump module; and

an in vitro analyte meter integrated with the insulin pump module.

3. The drug delivery system of claim 2, wherein the insulin pump module is an insulin pump.

4. The drug delivery system of claim 2, wherein the insulin pump module is an insulin pump controller.

5. The drug delivery system of claim 1, wherein the slot is dimensioned so that it does not apply pressure to the test strip when the test strip is passed therethrough.

6. The drug delivery system of claim 1, wherein the area of the slot is less than the area of the port.

7. The drug delivery system of claim 1, wherein the slot is dimensioned to provide a clearance between a surface of the port protector and a surface of the test strip when the test strip is passed therethrough.

8. The drug delivery system of claim 1, wherein the port protector is removably attachable to the port.

9. The drug delivery system of claim 1, wherein the port protector is fixedly attachable to the port.

10. The drug delivery system of claim 1, wherein the engagement feature comprises adhesive.

11. The drug delivery system of claim 1, wherein the in vitro analyte test strip is a glucose test strip.

12. The drug delivery system of claim 11, wherein the glucose test strip analyzes glucose in a sample of no more than about 1 microliter.

13. The drug delivery system of claim 12, wherein the glucose test strip analyzes glucose in a sample of no more than about 0.5 microliter.

14. The drug delivery system of claim 13, wherein the glucose test strip analyzes glucose in a sample of no more than about 0.2 microliter.

15. The drug delivery system of claim 1, wherein the in vitro analyte test strip is a ketone test strip.